Prospective evaluation of the predictive value of a circulating tumor cell (CTC) sensitivity profile to Cisplatin chemotherapy in metastatic breast cancer patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-005395-34

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To establish whether single-agent cDDP yields a response rate considered worthwhile to be further explored in metastatic breast cancer patients with more than 5 CTCs/7.5 mL of blood harboring a favorable CTC cDDP-sensitivity profile.


Critère d'inclusion

  • Metastatic breast cancer

Liens